. 2011 Nov 18;6(11):e27921. doi: 10.1371/journal.pone.0027921

Table 4. SNPs associated with patient survival.

SNP/ Center	Number of	Number of	Per-allele^b		A/A vs. A/B^b		A/A vs. B/B^b		A/A vs. A/B+B/B^b
	subjects^a	deaths^a	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p	HR (95% CI)	p
rs12029406 1q32.1 ( *NR5A2* )
Heidelberg	503	418	1.13 (0.99–1.29)	0.07	1.22 (0.99–1.51)	0.06	1.23 (0.92–1.63)	0.16	1.23 (1.01–1.49)	0.04
Liverpool	99	85	0.92 (0.68–1.24)	0.58	1.00 (0.63–1.58)	1.00	0.79 (0.40–1.55)	0.49	0.94 (0.61–1.45)	0.78
rs8028529 15q14 (gene desert)
Heidelberg	508	418	0.84 (0.71–0.99)	0.04	0.73 (0.59–0.91)	0.01	0.93 (0.62–1.41)	0.74	0.76 (0.62–0.93)	0.01
Liverpool	108	93	0.76 (0.55–1.05)	0.10	0.96 (0.61–1.51)	0.86	0.40 (0.16–1.01)	0.05	0.80 (0.52–1.22)	0.30

Numbers may not add up to 100% of subjects due to genotyping failure. All samples that did not give a reliable result in the first round of genotyping were resubmitted to up to two additional rounds of genotyping. Data points that were still not filled after this procedure were left blank.

HR: hazard ratio; CI: confidence interval. Age and gender did not show statistically significant association with survival, therefore were not used as adjustment variables. Associations approaching statistical significance are reported in bold.